4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

A new guideline for the management of patients with ventricular arrhythmias and the
prevention of sudden cardiac death has been published by the European Society of …

Pediatric cardiomyopathies (CMs) and electrical diseases constitute a heterogeneous
spectrum of disorders distinguished by structural and electrical abnormalities in the heart …

Primary electrical heart diseases, often considered channelopathies, are inherited genetic
abnormalities of cardiomyocyte electrical behavior carrying the risk of malignant arrhythmias …

Background Despite recent advances in drug discovery, cancer is still one of the most lethal
health problems worldwide. In most cases, standard therapy methods and multi-modal …

Cardiovascular diseases are the main cause of sudden cardiac death (SCD) in developed
and developing countries. Inherited cardiac channelopathies are linked to 5–10% of SCDs …

Background: Glioblastoma multiforme (GBM) is a lethal form of central nervous system
cancer with a lack of efficient therapy options. Aggressiveness and invasiveness of the GBM …

Inherited arrhythmia syndromes are a common cause of apparently unexplained cardiac
arrest or sudden cardiac death. These include long QT syndrome and Brugada syndrome …

Short QT (SQT) syndrome is a genetic cardiac disorder characterized by an abbreviated QT
interval of the patient's electrocardiogram. The syndrome is associated with increased risk of …

The clinical significance of optimal pharmacotherapy for inherited arrhythmias such as short
QT syndrome (SQTS) and long QT syndrome (LQTS) has been increasingly recognised. The …